Antimicrobial resistance and associated genes identified in extended-spectrum β-lactamases-producing Escherichia coli and Klebsiella pneumoniae
Yuemei Lu
Abstract
Yuemei Lu
Abstract
Objective To investigate the resistance and prevalence of extended-spectrumβ-lactamases (ESBLs) genotypes in Escherichia coli and Klebsiella pneumoniae which were isolated from lower respiratory tract between Jan 2002 and Dec 2003 in Shenzhen People's Hospital. Methods Sixty-one strains were confirmed as ESBLs-positive with inhibitor-potentiated test. The MICs were determined by agar dilution. ESBL genotypes were analyzed by PCR and nucleotide sequencing analysis. Results The susceptibility rate of ESBLs- producing strains were 100% to imipenem, MIC90 0. 5 mg/L. A total of 10 genotypes ofβ-lactamases were identified in the 61 ESBLs- producing strains. CTX-M type was identified in 83. 6% of the strains, including CTX-M-14 in 38 strains. SHV type was identified in 44. 3% of the strains, including SHV-12 in 20 strains. SHV genotype was identified only in K. pneumoniae. TEM type was identified in 37. 7% of the isolates. All of them were TEM-1. Conclusions ESBLs-producing E. coli and K. pneumoniae strains isolated from lower respiratory tract are highly resistant. Most strains are resistant to multiple drugs. CTX-M-type is the predominant ESBL genotypes in E. coli and K. pneumoniae, followed by SHV-type. Moreover, the distribution of ESBL genotypes is different in E. coli and K. pneumoniae, which may contribute to the different resistance patterns.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the resistance and prevalence of extended-spectrumβ-lactamases (ESBLs) genotypes in Escherichia coli and Klebsiella pneumoniae which were isolated from lower respiratory tract between Jan 2002 and Dec 2003 in Shenzhen People's Hospital. Methods Sixty-one strains were confirmed as ESBLs-positive with inhibitor-potentiated test. The MICs were determined by agar dilution. ESBL genotypes were analyzed by PCR and nucleotide sequencing analysis. Results The susceptibility rate of ESBLs- producing strains were 100% to imipenem, MIC90 0. 5 mg/L. A total of 10 genotypes ofβ-lactamases were identified in the 61 ESBLs- producing strains. CTX-M type was identified in 83. 6% of the strains, including CTX-M-14 in 38 strains. SHV type was identified in 44. 3% of the strains, including SHV-12 in 20 strains. SHV genotype was identified only in K. pneumoniae. TEM type was identified in 37. 7% of the isolates. All of them were TEM-1. Conclusions ESBLs-producing E. coli and K. pneumoniae strains isolated from lower respiratory tract are highly resistant. Most strains are resistant to multiple drugs. CTX-M-type is the predominant ESBL genotypes in E. coli and K. pneumoniae, followed by SHV-type. Moreover, the distribution of ESBL genotypes is different in E. coli and K. pneumoniae, which may contribute to the different resistance patterns.
Key concepts: Klebsiella pneumoniae, Microbiology, Biology, Imipenem, Genotype, Escherichia coli, Agar Dilution Method, Agar dilution